Janssen Sciences Ireland UC

Lobbying Organisation Janssen Sciences Ireland UC

Date published 20 Sep, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2025 to 31 Aug, 2025

Specific Details Engagement with Albert Nolan TD on biopharma policy priorities

Intended results To promote the adoption of a holistic national life sciences sector strategy by the Government To improve patient access to innovative medicinal products in Ireland

Name of person primarily responsible for lobbying on this activity Brita O'Reilly

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Meeting in Leinster House

Email (2-5)

Emails exchanged before and after meeting in Leinster House in relation to policy topics discussed

Submission (2-5)

IPHA documents on the national life sciences strategy and on 'Fairer and Faster Patient Access to New Medicines' shared via email

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Albert Dolan TD (Dáil Éireann, the Oireachtas)